Terms of Reference

The availability of new, innovative and specialist cancer drugs in Australia, with particular reference to:

  1. the timing and affordability of access for patients; 
  2. the operation of the Pharmaceutical Benefits Advisory Committee and the Pharmaceutical Benefits Scheme in relation to such drugs, including the impact of delays in the approvals process for Australian patients; 
  3. the impact on the quality of care available to cancer patients; and 
  4. any related matters.

Committee Secretariat contact:

Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3515
Fax: +61 2 6277 5829
community.affairs.sen@aph.gov.au

Top